Fidelity Select Pharmaceuticals Portfolio (FPHAX)
NASDAQ · Mutual Fund · Delayed Price · Currency is USD
30.60
+0.18 (0.59%)
May 1, 2026, 4:00 PM EST
FPHAX Holdings Information
FPHAX is a mutual fund with a total of 61 individual holdings. The top holdings are Eli Lilly and Company stock at 25.18%, GSK plc at 10.07%, Johnson & Johnson at 7.53%, UCB SA at 5.01%, and Roche Holding AG at 4.93%.
Total Holdings
61
Top 10 Percentage
74.55%
Asset Class
Equity
Fund Category
Health
Assets
1.40B
Forward PE Ratio
18.71
Breakdown by Sector
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 25.18% |
| 2 | GSK | GSK plc | 10.07% |
| 3 | JNJ | Johnson & Johnson | 7.53% |
| 4 | EBR: UCB | UCB SA | 5.01% |
| 5 | SWX: ROP | Roche Holding AG | 4.93% |
| 6 | LON: AZN | AstraZeneca PLC | 4.93% |
| 7 | GILD | Gilead Sciences, Inc. | 4.64% |
| 8 | MRK | Merck & Co., Inc. | 4.59% |
| 9 | ELAN | Elanco Animal Health Incorporated | 4.42% |
| 10 | LEGN | Legend Biotech Corporation | 3.26% |
| 11 | JAZZ | Jazz Pharmaceuticals plc | 2.85% |
| 12 | MRNA | Moderna, Inc. | 2.43% |
| 13 | RPRX | Royalty Pharma plc | 2.29% |
| 14 | VTRS | Viatris Inc. | 1.70% |
| 15 | EBR: TUB | Financière de Tubize SA | 1.62% |
| 16 | BNTX | BioNTech SE | 0.96% |
| 17 | ETR: MRK | Merck KGaA | 0.95% |
| 18 | BIIB | Biogen Inc. | 0.92% |
| 19 | OCUL | Ocular Therapeutix, Inc. | 0.79% |
| 20 | BEAM | Beam Therapeutics Inc. | 0.78% |
| 21 | XENE | Xenon Pharmaceuticals Inc. | 0.77% |
| 22 | QURE | uniQure N.V. | 0.73% |
| 23 | CAPR | Capricor Therapeutics, Inc. | 0.72% |
| 24 | PTCT | PTC Therapeutics, Inc. | 0.70% |
| 25 | KYMR | Kymera Therapeutics, Inc. | 0.61% |
As of Feb 28, 2026